Journal of Preventive Medicine and Public Health

  • 제48권6호
  • /
  • Pages.280-286
  • /
  • 2015
  • /
  • 1975-8375(pISSN)
  • /
  • 2233-4521(eISSN)
대한예방의학회 (The Korean Society for Preventive Medicine)
권호 표지
DOI QR코드

DOI QR Code

Hormonal Replacement Therapy and the Risk of Lung Cancer in Women: An Adaptive Meta-analysis of Cohort Studies

  • Bae, Jong-Myon (Department of Preventive Medicine, Jeju National University School of Medicine) ;
  • Kim, Eun Hee (Department of Preventive Medicine, Jeju National University School of Medicine)
  • 투고 : 2015.09.18
  • 심사 : 2015.10.28
  • 발행 : 2015.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: Approximately 10% to 15% of lung cancer cases occur in never-smokers. Hormonal factors have been suggested to lead to an elevated risk of lung cancer in women. This systematic review (SR) aimed to investigate the association between hormonal replacement therapy (HRT) and the risk of lung cancer in women using cohort studies. Methods: We first obtained previous SR articles on this topic. Based on these studies we made a list of refereed, cited, and related articles using the PubMed and Scopus databases. All cohort studies that evaluated the relative risk of HRT exposure on lung cancer occurrence in women were selected. Estimate of summary effect size (sES) with 95% confidence intervals (CIs) were calculated. Results: A total of 14 cohort studies were finally selected. A random effect model was applied due to heterogeneity (I-squared, 64.3%). The sES of the 14 articles evaluating the impact of HRT exposure on lung cancer occurrence in women indicated no statistically significant increase in lung cancer risk (sES, 0.99; 95% CI, 0.90 to 1.09). Conclusions: These results showed that HRT history had no effect on the risk of lung cancer in women, even though the sES of case-control studies described in previous SR articles indicated that HRT had a protective effect against lung cancer. It is necessary to conduct a pooled analysis of cohort studies.

키워드

참고문헌

  1. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47(2):127-141. https://doi.org/10.4143/crt.2015.060
  2. Bae JM, Li ZM, Shin MH, Kim DH, Lee MS, Ahn YO. Lung cancer incidence by smoking status in Korean men: 16-years of observations in the Seoul Male Cancer Cohort study. J Korean Med Sci 2013;28(4):636-637. https://doi.org/10.3346/jkms.2013.28.4.636
  3. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med 2011;32(4):605-644. https://doi.org/10.1016/j.ccm.2011.09.001
  4. Thun MJ, Henley SJ, Burns D, Jemal A, Shanks TG, Calle EE. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst 2006;98(10):691-699. https://doi.org/10.1093/jnci/djj187
  5. Planchard D, Besse B. Lung cancer in never-smokers. Eur Respir J 2015;45(5):1214-1217. https://doi.org/10.1183/09031936.00046915
  6. Alberg AJ, Wallace K, Silvestri GA, Brock MV. Invited commentary: the etiology of lung cancer in men compared with women. Am J Epidemiol 2013;177(7):613-616. https://doi.org/10.1093/aje/kws444
  7. Subramanian J, Govindan R. Lung cancer in 'Never-smokers': a unique entity. Oncology (Williston Park) 2010;24(1):29-35.
  8. Krishnan VG, Ebert PJ, Ting JC, Lim E, Wong SS, Teo AS, et al. Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers. Cancer Res 2014; 74(21):6071-6081. https://doi.org/10.1158/0008-5472.CAN-13-3195
  9. Chakraborty S, Ganti AK, Marr A, Batra SK. Lung cancer in women: role of estrogens. Expert Rev Respir Med 2010;4(4):509-518. https://doi.org/10.1586/ers.10.50
  10. Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol 2007;25(5):561-570. https://doi.org/10.1200/JCO.2006.06.8015
  11. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers--a different disease. Nat Rev Cancer 2007;7(10):778-790. https://doi.org/10.1038/nrc2190
  12. Siegfried JM. Women and lung cancer: does oestrogen play a role? Lancet Oncol 2001;2(8):506-513. https://doi.org/10.1016/S1470-2045(01)00457-0
  13. Meireles SI, Esteves GH, Hirata R Jr, Peri S, Devarajan K, Slifker M, et al. Early changes in gene expression induced by tobacco smoke: evidence for the importance of estrogen within lung tissue. Cancer Prev Res (Phila) 2010;3(6):707-717. https://doi.org/10.1158/1940-6207.CAPR-09-0162
  14. Oh SW, Myung SK, Park JY, Lym YL, Ju W. Hormone therapy and risk of lung cancer: a meta-analysis. J Womens Health (Larchmt) 2010;19(2):279-288. https://doi.org/10.1089/jwh.2009.1434
  15. Greiser CM, Greiser EM, Doren M. Menopausal hormone therapy and risk of lung cancer-Systematic review and meta-analysis. Maturitas 2010;65(3):198-204. https://doi.org/10.1016/j.maturitas.2009.11.027
  16. Chen X, Cai L. Meta-analysis of the effects on hormone replacement therapy and oral contraceptives associated with female lung cancer risk. Wei Sheng Yan Jiu 2009;38(6):672-676 (Chinese).
  17. Yao Y, Gu X, Zhu J, Yuan D, Song Y. Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis. PLoS One 2013;8(8):e71236. https://doi.org/10.1371/journal.pone.0071236
  18. Pesatori AC, Carugno M, Consonni D, Hung RJ, Papadoupolos A, Landi MT, et al. Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). Br J Cancer 2013;109(7):1954-1964. https://doi.org/10.1038/bjc.2013.506
  19. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989;44(5):833-839. https://doi.org/10.1002/ijc.2910440515
  20. Persson I, Yuen J, Bergkvist L, Schairer C. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort. Int J Cancer 1996;67(3):327-332. https://doi.org/10.1002/(SICI)1097-0215(19960729)67:3<327::AID-IJC4>3.0.CO;2-T
  21. Bae JM. Narrative reviews. Epidemiol Health 2014;36:e2014018.
  22. Bae JM. Human papillomavirus 16 infection as a potential risk factor for prostate cancer: an adaptive meta-analysis. Epidemiol Health 2015;37:e2015005. https://doi.org/10.4178/epih/e2015005
  23. Bae JM. The necessity of an observational study on the interactions between allergic history and citrus fruit intake for the prevention of pancreatic cancer. Epidemiol Health 2015;37: e2015028. https://doi.org/10.4178/epih/e2015028
  24. Pukkala E, Tulenheimo-Silfvast A, Leminen A. Incidence of cancer among women using long versus monthly cycle hormonal replacement therapy, Finland 1994-1997. Cancer Causes Control 2001;12(2):111-115. https://doi.org/10.1023/A:1008934919159
  25. Olsson H, Bladstrom A, Ingvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 2003;102(3):565-570. https://doi.org/10.1016/S0029-7844(03)00564-7
  26. Liu Y, Inoue M, Sobue T, Tsugane S. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer 2005;117(4):662-666. https://doi.org/10.1002/ijc.21229
  27. Kabat GC, Miller AB, Rohan TE. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer 2007;120(10):2214-2220. https://doi.org/10.1002/ijc.22543
  28. Corrao G, Zambon A, Conti V, Nicotra F, La Vecchia C, Fornari C, et al. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation. Ann Oncol 2008; 19(1):150-155. https://doi.org/10.1093/annonc/mdn335
  29. Rodriguez C, Spencer Feigelson H, Deka A, Patel AV, Jacobs EJ, Thun MJ, et al. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2008;17(3):655-660. https://doi.org/10.1158/1055-9965.EPI-07-2683
  30. Smith JR, Barrett-Connor E, Kritz-Silverstein D, Wingard DL, Al-Delaimy WK. Hormone use and lung cancer incidence: the Rancho Bernardo cohort study. Menopause 2009;16(5):1044-1048. https://doi.org/10.1097/gme.0b013e3181a1ba04
  31. Slatore CG, Chien JW, Au DH, Satia JA, White E. Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol 2010;28(9):1540-1546. https://doi.org/10.1200/JCO.2009.25.9739
  32. Clague J, Reynolds P, Sullivan-Halley J, Ma H, Lacey JV Jr, Henderson KD, et al. Menopausal hormone therapy does not influence lung cancer risk: results from the California Teachers Study. Cancer Epidemiol Biomarkers Prev 2011;20(3):560-564. https://doi.org/10.1158/1055-9965.EPI-10-1182
  33. Brinton LA, Schwartz L, Spitz MR, Park Y, Hollenbeck AR, Gierach GL. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Causes Control 2012;23(3):487-496. https://doi.org/10.1007/s10552-012-9904-2
  34. Brinton LA, Gierach GL, Andaya A, Park Y, Schatzkin A, Hollenbeck AR, et al. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev 2011;20(5):900-911. https://doi.org/10.1158/1055-9965.EPI-10-1325
  35. Weiss JM, Lacey JV Jr, Shu XO, Ji BT, Hou L, Yang G, et al. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 2008; 168(11):1319-1325. https://doi.org/10.1093/aje/kwn257
  36. Seow A, Koh WP, Wang R, Lee HP, Yu MC. Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 2009;18(3):821-827. https://doi.org/10.1158/1055-9965.EPI-08-0892
  37. Baik CS, Strauss GM, Speizer FE, Feskanich D. Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev 2010;19(10):2525-2533. https://doi.org/10.1158/1055-9965.EPI-10-0450
  38. Bae JM, Lee EJ, Guyatt G. Citrus fruit intake and stomach cancer risk: a quantitative systematic review. Gastric Cancer 2008; 11(1):23-32. https://doi.org/10.1007/s10120-007-0447-2
  39. Bae JM, Lee EJ, Guyatt G. Citrus fruit intake and pancreatic cancer risk: a quantitative systematic review. Pancreas 2009;38(2): 168-174. https://doi.org/10.1097/MPA.0b013e318188c497
  40. Siegfried JM. Smoking out reproductive hormone actions in lung cancer. Mol Cancer Res 2014;12(1):24-31. https://doi.org/10.1158/1541-7786.MCR-13-0580
  41. Koushik A, Spiegelman D, Albanes D, Anderson KE, Bernstein L, van den Brandt PA, et al. Intake of fruits and vegetables and risk of pancreatic cancer in a pooled analysis of 14 cohort studies. Am J Epidemiol 2012;176(5):373-386. https://doi.org/10.1093/aje/kws027

피인용 문헌

  1. Human papillomavirus infection and risk of lung cancer in never-smokers and women: an ‘adaptive’ meta-analysis vol.37, pp.None, 2015, https://doi.org/10.4178/epih/e2015052
  2. Osteoporosis: Modern Paradigms for Last Century’s Bones vol.8, pp.6, 2015, https://doi.org/10.3390/nu8060376
  3. Dietary intakes of citrus fruit and risk of gastric cancer incidence: an adaptive meta-analysis of cohort studies vol.38, pp.None, 2016, https://doi.org/10.4178/epih.e2016034
  4. Citation Discovery Tools for Conducting Adaptive Meta-analyses to Update Systematic Reviews vol.49, pp.2, 2015, https://doi.org/10.3961/jpmph.15.074
  5. Exploring estrogenic activity in lung cancer vol.44, pp.1, 2015, https://doi.org/10.1007/s11033-016-4086-8
  6. Biases Inherent in Studies of Coffee Consumption in Early Pregnancy and the Risks of Subsequent Events vol.10, pp.9, 2015, https://doi.org/10.3390/nu10091152
  7. Hormone replacement therapy and lung cancer risk in women: a meta-analysis of cohort studies : Hormone replacement therapy and lung cancer risk vol.98, pp.51, 2015, https://doi.org/10.1097/md.0000000000017532
  8. We need to educate young lung cancer patients about menopause risk vol.8, pp.1, 2015, https://doi.org/10.2217/lmt-2018-0018
  9. Female reproductive factors and the risk of lung cancer in postmenopausal women: a nationwide cohort study vol.122, pp.9, 2015, https://doi.org/10.1038/s41416-020-0789-7
  10. Protective effects of 17-β-oestradiol and phytoestrogen on age-induced oxidative stress and inhibition of surfactant synthesis in rat type II pneumocytes vol.72, pp.1, 2015, https://doi.org/10.1080/09637486.2020.1757044
  11. Hormone replacement therapy and cancer survival: a longitudinal cohort study: protocol paper vol.11, pp.8, 2015, https://doi.org/10.1136/bmjopen-2020-046701
  12. Associations between female lung cancer risk and sex steroid hormones: a systematic review and meta-analysis of the worldwide epidemiological evidence on endogenous and exogenous sex steroid hormones vol.21, pp.1, 2015, https://doi.org/10.1186/s12885-021-08437-9